Data Tables

View HTML		View PDF
Section I
1.1	U.S. Organ Donors by Organ and Donor Type, 1997 to 2006	(29 k)
1.2	Number of Organs Recovered from Deceased Donors, 1997 to 2006	(24 k)
1.3	Waiting List at End of Year, 1997 to 2006	(27 k)
1.4	Characteristics of Waiting List Patients at End of Year, 1997 to 2006	(36 k)
	Age
	Blood Type
	Residency
	Gender
	Previous Transplant Any Organ
	Race
	Patient Status
1.5	Time to Transplant New Waiting List Registrations, 1997 to 2006	(35 k)
1.6	Reported Deaths and Annual Death Rates Per 1,000 Patient-Years at Risk Waiting List, 1997 to 2006	(29 k)
1.7	Transplants by Organ and Donor Type, 1997 to 2006	(29 k)
1.8	Multi-Organ Transplants, 1997 to 2006	(26 k)
1.9a	Immunosuppression Use by Organ in 2005 and 2006	(34 k)
1.9b	Immunosuppression Use by Organ Maintenance Regimen at Discharge, 2006 Transplants	(31 k)
1.9c	Immunosuppression Use by Organ Maintenance Regimen at One Year Following Transplantation 2005 Transplants	(31 k)
1.10	Transplant Recipient Characteristics, 1997 to 2006	(36 k)
	Blood Type
	Residency
	Gender
	Race
	Age
	Previous Transplant Any Organ
	Payment Source
1.11a	One Year Adjusted Graft Survival by Organ and Year of Transplant, 1996 to 2005	(31 k)
1.11b	One Year Unadjusted Graft Survival by Organ and Year of Transplant, 1996 to 2005	(31 k)
1.12a	One Year Adjusted Patient Survival by Organ and Year of Transplant, 1996 to 2005	(31 k)
1.12b	One Year Unadjusted Patient Survival by Organ and Year of Transplant, 1996 to 2005	(31 k)
1.13	Unadjusted Graft and Patient Survival at 3 Months, 1 Year, 3 Years, 5 Years, and 10 Years Standard Errors of the Survival Rates	(37 k)
	Standard Errors of the Survival Rates
	Survival (%)
	Number of Transplants For This Survival Analysis
1.14	Prevalence of People Living with a Functioning Transplant at End of Year 1997 to 2005	(20 k)
Section II
2.1	Deceased Donor Characteristics, 1997 to 2006 Deceased Donors of Any Organ	(45 k)
	Age
	Blood Type
	Cause of Death
	Circumstance of Death
	Mechanism of Death
	Gender
	Donation After Cardiac Death
	Race
2.2	Deceased Donor Characteristics, 1997 to 2006 Kidney Donors	(47 k)
	Age
	Blood Type
	Cause of Death
	Circumstance of Death
	Mechanism of Death
	Gender
	Race
	Donor Type
2.3	Deceased Donor Characteristics, 1997 to 2006 Pancreas Donors	(44 k)
	Age
	Blood Type
	Cause of Death
	Circumstance of Death
	Mechanism of Death
	Gender
	Donation After Cardiac Death
	Race
2.4	Deceased Donor Characteristics, 1997 to 2006 Liver Donors	(45 k)
	Age
	Blood Type
	Cause of Death
	Circumstance of Death
	Mechanism of Death
	Gender
	Donation After Cardiac Death
	Race
2.5	Deceased Donor Characteristics, 1997 to 2006 Intestine Donors	(44 k)
	Age
	Blood Type
	Cause of Death
	Circumstance of Death
	Mechanism of Death
	Gender
	Donation After Cardiac Death
	Race
2.6	Deceased Donor Characteristics, 1997 to 2006 Heart Donors	(44 k)
	Age
	Blood Type
	Cause of Death
	Circumstance of Death
	Mechanism of Death
	Gender
	Race
2.7	Deceased Donor Characteristics, 1997 to 2006 Lung Donors	(44 k)
	Age
	Blood Type
	Cause of Death
	Circumstance of Death
	Mechanism of Death
	Gender
	Donation After Cardiac Death
	Race
2.8	Living Donor Characteristics, 1997 to 2006 Living Donors of Any Organ	(35 k)
	Age
	Blood Type
	Gender
	Race
	Donor Relation
2.9	Living Donor Characteristics, 1997 to 2006 Kidney Donors	(35 k)
	Age
	Blood Type
	Gender
	Race
	Donor Relation
2.10	Living Donor Characteristics, 1997 to 2006 Liver Segment Donors	(34 k)
	Age
	Blood Type
	Gender
	Race
	Donor Relation
2.11	Living Donor Characteristics, 1997 to 2006 Lung Lobe Donors	(34 k)
	Age
	Blood Type
	Gender
	Race
	Donor Relation
2.12	Deceased Donor Organ Utilization, 1997 to 2006, Any Organ	(32 k)
2.13	Deceased Donor Organ Utilization, 1997 to 2006, Kidney	(37 k)
2.14	Deceased Donor Organ Utilization, 1997 to 2006, Pancreas	(36 k)
2.15	Deceased Donor Organ Utilization, 1997 to 2006, Liver	(36 k)
2.16	Deceased Donor Organ Utilization, 1997 to 2006, Intestine	(36 k)
2.17	Deceased Donor Organ Utilization, 1997 to 2006, Heart	(36 k)
2.18	Deceased Donor Organ Utilization, 1997 to 2006, Lung	(36 k)
Section III
3.1	Disposition of Organs Recovered from Deceased Donors, 1997 to 2006 Kidney	(27 k)
3.2	Reasons for Non-Use of Recovered Organs, 1997 to 2006 Kidney	(30 k)
3.3	Reasons for Non-Recovery of Consented Organs, 1997 to 2006 Kidney	(29 k)
3.4	Disposition of Organs Recovered from Deceased Donors, 1997 to 2006 Pancreas	(27 k)
3.5	Reasons for Non-Use of Recovered Organs, 1997 to 2006 Pancreas	(30 k)
3.6	Reasons for Non-Recovery of Consented Organs, 1997 to 2006 Pancreas	(29 k)
3.7	Disposition of Organs Recovered from Deceased Donors, 1997 to 2006 Liver	(28 k)
3.8	Reasons for Non-Use of Recovered Organs, 1997 to 2006 Liver	(29 k)
3.9	Reasons for Non-Recovery of Consented Organs, 1997 to 2006 Liver	(29 k)
3.10	Disposition of Organs Recovered from Deceased Donors, 1997 to 2006 Intestine	(26 k)
3.11	Reasons for Non-Use of Recovered Organs, 1997 to 2006 Intestine	(29 k)
3.12	Reasons for Non-Recovery of Consented Organs, 1997 to 2006 Intestine	(29 k)
3.13	Disposition of Organs Recovered from Deceased Donors, 1997 to 2006 Heart	(27 k)
3.14	Reasons for Non-Use of Recovered Organs, 1997 to 2006 Heart	(29 k)
3.15	Reasons for Non-Recovery of Consented Organs, 1997 to 2006 Heart	(29 k)
3.16	Disposition of Organs Recovered from Deceased Donors, 1997 to 2006 Lung	(27 k)
3.17	Reasons for Non-Use of Recovered Organs, 1997 to 2006 Lung	(29 k)
3.18	Reasons for Non-Recovery of Consented Organs, 1997 to 2006 Lung	(29 k)
Section IV
4.1	Deceased Donors Procured by U.S. Organ Procurement Organizations 1997 to 2006	(47 k)
4.2	Transplant Centers Within Each OPO CMS-Designated Service Area As of May 2007, By Home State of OPO	(67 k)
Section V
5.1a	Waiting List Patient Characteristics at End of Year Kidney Waiting List Active Waitlist Patients, 1997 to 2006	(44 k)
	Age
	Blood Type
	Residency
	Diagnosis
	Gender
	Previous Transplant Any Organ
	Race
	PRA
	Previous Transplant Same Organ
	Time on Waiting List
5.1b	Waiting List Patient Characteristics at End of Year Kidney Waiting List Active and Inactive Patient Comparison, 2002 to 2006	(38 k)
	Age
	Diagnosis
	Gender
	Race
	Time on Waiting List
5.2	Time to Transplant, 1997 to 2006 New Kidney Waiting List Registrations	(98 k)
	Blood Type
	Age
	Gender
	All Patient Types
	PRA
	Gender and PRA
	Race and PRA
	Previous Transplant Any Organ
	Previous Transplant and Gender
	Previous Transplant and PRA
	Previous Transplant and Race
	Race
	Residency
5.3	Reported Deaths and Annual Death Rates Per 1,000 Patient-Years at Risk, 1997 to 2006 Kidney Waiting List	(50 k)
	Age
	Blood Type
	Diagnosis
	Gender
	Race
5.4	Transplant Recipient Characteristics, 1997 to 2006 Recipients of Deceased Donor Kidneys	(28 k)
5.4a	Transplant Recipient Characteristics, 1997 to 2006 Recipients of Deceased Donor non-ECD Kidneys	(57 k)
	Age
	Blood Type
	Residency
	Gender
	PRA
	Race
	Diagnosis
	Cold Ischemic Time
	Hospitalized at Tx
	Level of HLA Mismatch
	PRA
	Previous Transplant Same Organ
	Previous Transplant Any Organ
	Payment Source
5.4b	Transplant Recipient Characteristics, 1997 to 2006 Recipients of Deceased Donor Expanded Criteria Donors (ECD) Kidneys	(56 k)
	Age
	Blood Type
	Residency
	Gender
	PRA
	Race
	Diagnosis
	Cold Ischemic Time
	Hospitalized at Tx
	Level of HLA Mismatch
	PRA
	Previous Transplant Same Organ
	Previous Transplant Any Organ
	Payment Source
5.4c	Transplant Recipient Characteristics, 1997 to 2006 Recipients of Living Donor Kidneys	(55 k)
	Age
	Blood Type
	Residency
	Gender
	PRA
	Race
	Donor Relation
	Diagnosis
	Hospitalized at Tx
	Level of HLA Mismatch
	PRA
	Previous Transplant Same Organ
	Previous Transplant Any Organ
	Payment Source
5.5	Incidence of Transplant, 1997 to 2006 Kidney Transplants per 1 Million Population	(29 k)
5.6a	Immunosuppression Use for Induction, 1997 to 2006 Recipients with Kidney Transplants	(29 k)
5.6b	Immunosuppression Use for Induction by Discharge Regimen, 2002 to 2006 Recipients with Kidney Transplants	(31 k)
5.6c	Immunosuppression Use for Induction by Steroid Use at Discharge, 2002 to 2006 Recipients with Kidney Transplants	(29 k)
5.6d	Immunosuppression Use for Maintenance by Regimen Prior to Discharge, 1997 to 2006 Recipients with Kidney Transplants	(30 k)
5.6e	Immunosuppression Use for Maintenance Prior to Discharge, 1997 to 2006 Recipients with Kidney Transplants	(31 k)
5.6f	Immunosuppression Use for Maintenance by Regimen One Year Following Transplantation, 1996 to 2005 Recipients with Kidney Transplants	(31 k)
5.6g	Immunosuppression Use for Maintenance Between Discharge and One Year Following Transplantation, 1996 to 2005 Recipients with Kidney Transplants	(31 k)
5.6h	Persistency of Discharge Regimen by Follow-up Period, 2001 to 2005 Recipients with Kidney Transplants	(34 k)
5.6i	Immunosuppression Use for Antirejection Treatment from Transplant to One Year Following Transplantation, 1996 to 2005 Recipients with Kidney Transplants	(30 k)
5.7a	Patients and Annual Death Rates Per 1,000 Patient-Years at Risk, 1997 to 2005 Rates for Recipients during First Year after Deceased Donor non-ECD Kidney Transplantation	(89 k)
	Blood Type
	Residency
	Gender
	PRA
	Race
	Donor Age
	Age
	Cold Ischemic Time
	Hospitalized at Tx
	Level of HLA Mismatch
	Previous Transplant Any Organ
	Diagnosis
5.7b	Patients and Annual Death Rates Per 1,000 Patient-Years at Risk, 1997 to 2005 Rates for Recipients during First Year after Deceased Donor ECD Kidney Transplantation	(85 k)
	Blood Type
	Residency
	Gender
	PRA
	Race
	Donor Age
	Age
	Cold Ischemic Time
	Hospitalized at Tx
	Level of HLA Mismatch
	Previous Transplant Any Organ
	Diagnosis
5.7c	Patients and Annual Death Rates Per 1,000 Patient-Years at Risk, 1997 to 2005 Rates for Recipients during First Year after Living Donor Kidney Transplantation	(78 k)
	Blood Type
	Residency
	Gender
	PRA
	Race
	Donor Age
	Age
	Hospitalized at Tx
	Level of HLA Mismatch
	Previous Transplant Any Organ
	Diagnosis
5.8a	Adjusted Graft Survival, Deceased Donor non-ECD Kidney Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 Years	(39 k)
	Age
	Gender
	Race
	Diagnosis
5.8b	Adjusted Graft Survival, Deceased Donor ECD Kidney Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 Years	(38 k)
	Age
	Gender
	Race
	Diagnosis
5.8c	Adjusted Graft Survival, Living Donor Kidney Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 Years	(38 k)
	Age
	Gender
	Race
	Diagnosis
5.9a	Adjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Deceased Donor non-ECD Kidney Transplants	(22 k)
5.9b	Adjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Deceased Donor ECD Kidney Transplants	(23 k)
5.9c	Adjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Living Donor Kidney Transplants	(22 k)
5.10a	Unadjusted Graft Survival, Deceased Donor non-ECD Kidney Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 Years	(49 k)
	Age
	Blood Type
	Residency
	Gender
	PRA
	Race
	Center Volume
	Donor Age
	Previous Transplant Same Organ
	Diagnosis
	Dialysis Within 1 Week of Tx
	Cold Ischemic Time
	On Life Support at Tx
	Hospitalized at Tx
	Level of HLA Mismatch
5.10b	Unadjusted Graft Survival, Deceased Donor ECD Kidney Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 Years	(48 k)
	Age
	Blood Type
	Residency
	Gender
	PRA
	Race
	Center Volume
	Donor Age
	Previous Transplant Same Organ
	Diagnosis
	Dialysis Within 1 Week of Tx
	Cold Ischemic Time
	On Life Support at Tx
	Hospitalized at Tx
	Level of HLA Mismatch
5.10c	Unadjusted Graft Survival, Living Donor Kidney Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 Years	(49 k)
	Age
	Blood Type
	Residency
	Gender
	PRA
	Race
	Center Volume
	Donor Relation
	Donor Age
	Previous Transplant Same Organ
	Diagnosis
	Dialysis Within 1 Week of Tx
	On Life Support at Tx
	Hospitalized at Tx
	Level of HLA Mismatch
5.11a	Unadjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Deceased Donor non-ECD Kidney Transplants	(23 k)
5.11b	Unadjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Deceased Donor ECD Kidney Transplants	(23 k)
5.11c	Unadjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Living Donor Kidney Transplants	(22 k)
5.12a	Adjusted Patient Survival, Deceased Donor non-ECD Kidney Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 Years	(38 k)
	Age
	Gender
	Race
	Diagnosis
5.12b	Adjusted Patient Survival, Deceased Donor ECD Kidney Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 Years	(38 k)
	Age
	Gender
	Race
	Diagnosis
5.12c	Adjusted Patient Survival, Living Donor Kidney Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 Years	(37 k)
	Age
	Gender
	Race
	Diagnosis
5.13a	Adjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Deceased Donor non-ECD Kidney Transplants	(22 k)
5.13b	Adjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Deceased Donor ECD Kidney Transplants	(23 k)
5.13c	Adjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Living Donor Kidney Transplants	(22 k)
5.14a	Unadjusted Patient Survival, Deceased Donor non-ECD Kidney Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 Years	(48 k)
	Age
	Blood Type
	Residency
	Gender
	PRA
	Race
	Center Volume
	Donor Age
	Diagnosis
	Dialysis Within 1 Week of Tx
	Cold Ischemic Time
	On Life Support at Tx
	Hospitalized at Tx
	Level of HLA Mismatch
5.14b	Unadjusted Patient Survival, Deceased Donor ECD Kidney Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 Years	(48 k)
	Age
	Blood Type
	Residency
	Gender
	PRA
	Race
	Center Volume
	Donor Age
	Diagnosis
	Dialysis Within 1 Week of Tx
	Cold Ischemic Time
	On Life Support at Tx
	Hospitalized at Tx
	Level of HLA Mismatch
5.14c	Unadjusted Patient Survival, Living Donor Kidney Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 Years	(48 k)
	Age
	Blood Type
	Residency
	Gender
	PRA
	Race
	Center Volume
	Donor Relation
	Donor Age
	Diagnosis
	Dialysis Within 1 Week of Tx
	On Life Support at Tx
	Hospitalized at Tx
	Level of HLA Mismatch
5.15a	Unadjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Deceased Donor non-ECD Kidney Transplants	(22 k)
5.15b	Unadjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Deceased Donor ECD Kidney Transplants	(23 k)
5.15c	Unadjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Living Donor Kidney Transplants	(22 k)
5.16	Prevalence of People Living with a Functioning Transplant at End of Year Kidney Recipients, 1997 to 2005	(48 k)
	Blood Type
	Residency
	Gender
	PRA
	Race
	Donor Type
	Age
	Diagnosis
	Hospitalized at Tx
	Level of HLA Mismatch
	PRA
	Previous Transplant Same Organ
	Previous Transplant Any Organ
5.17	Transplants by State and Transplant Center, 1997 to 2006 Kidney	(95 k)
Section VI
6.1a	Waiting List Patient Characteristics at End of Year Pancreas Transplant Alone (PTA) Waiting List Active Waitlist Patients, 1997 to 2006	(38 k)
	Age
	Blood Type
	Residency
	Gender
	Previous Transplant Any Organ
	Race
	Previous Transplant Same Organ
	Time on Waiting List
6.1b	Waiting List Patient Characteristics at End of Year Pancreas Transplant Alone (PTA) Waiting List Active and Inactive Patient Comparison, 2002 to 2006	(33 k)
	Age
	Gender
	Race
	Time on Waiting List
6.2	Time to Transplant, 1997 to 2006 New Pancreas Transplant Alone (PTA) Waiting List Registrations	(55 k)
	Blood Type
	Age
	Gender
	All Patient Types
	Previous Transplant Any Organ
	Race
	Residency
6.3	Reported Deaths and Annual Death Rates Per 1,000 Patient-Years at Risk, 1997 to 2006 Pancreas Transplant Alone (PTA) Waiting List	(40 k)
	Age
	Blood Type
	Gender
	Race
6.4	Transplant Recipient Characteristics, 1997 to 2006 Pancreas Transplant Alone (PTA) Recipients	(39 k)
	Age
	Blood Type
	Residency
	Gender
	Race
	Cold Ischemic Time
	Hospitalized at Tx
	Previous Transplant Same Organ
	Previous Transplant Any Organ
	Payment Source
6.5	Incidence of Transplant, 1997 to 2006 Pancreas Transplant Alone (PTA) Transplants per 1 Million Population	(29 k)
6.6a	Immunosuppression Use for Induction, 1997 to 2006 Recipients with Pancreas Transplant Alone (PTA) Transplants	(29 k)
6.6b	Immunosuppression Use for Induction by Discharge Regimen, 2002 to 2006 Recipients with Pancreas Transplant Alone (PTA) Transplants	(31 k)
6.6c	Immunosuppression Use for Induction by Steroid Use at Discharge, 2002 to 2006 Recipients with Pancreas Transplant Alone (PTA) Transplants	(29 k)
6.6d	Immunosuppression Use for Maintenance by Regimen Prior to Discharge, 1997 to 2006 Recipients with Pancreas Transplant Alone (PTA) Transplants	(30 k)
6.6e	Immunosuppression Use for Maintenance Prior to Discharge, 1997 to 2006 Recipients with Pancreas Transplant Alone (PTA) Transplants	(30 k)
6.6f	Immunosuppression Use for Maintenance by Regimen One Year Following Transplantation, 1996 to 2005 Recipients with Pancreas Transplant Alone (PTA) Transplants	(31 k)
6.6g	Immunosuppression Use for Maintenance Between Discharge and One Year Following Transplantation, 1996 to 2005 Recipients with Pancreas Transplant Alone (PTA) Transplants	(31 k)
6.6h	Persistency of Discharge Regimen by Follow-up Period, 2001 to 2005 Recipients with Pancreas Transplant Alone (PTA) Transplants	(33 k)
6.6i	Immunosuppression Use for Antirejection Treatment from Transplant to One Year Following Transplantation, 1996 to 2005 Recipients with Pancreas Transplant Alone (PTA) Transplants	(30 k)
6.7	Patients and Annual Death Rates Per 1,000 Patient-Years at Risk, 1997 to 2005 Rates for Recipients during First Year after Pancreas Transplant Alone (PTA) Transplantation	(66 k)
	Blood Type
	Residency
	Gender
	Race
	Donor Age
	Age
	Cold Ischemic Time
	Hospitalized at Tx
	Level of HLA Mismatch
	Previous Transplant Any Organ
6.8	Adjusted Graft Survival, Pancreas Transplant Alone (PTA) Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 Years	(30 k)
	Age
	Gender
	Race
6.9	Adjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Pancreas Transplant Alone (PTA) Transplants	(22 k)
6.10	Unadjusted Graft Survival, Pancreas Transplant Alone (PTA) Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 Years	(37 k)
	Age
	Blood Type
	Residency
	Gender
	Race
	Center Volume
	Donor Age
	Cold Ischemic Time
	Hospitalized at Tx
	Level of HLA Mismatch
6.11	Unadjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Pancreas Transplant Alone (PTA) Transplants	(22 k)
6.12	Adjusted Patient Survival, Pancreas Transplant Alone (PTA) Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 Years	(30 k)
	Age
	Gender
	Race
6.13	Adjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Pancreas Transplant Alone (PTA) Transplants	(22 k)
6.14	Unadjusted Patient Survival, Pancreas Transplant Alone (PTA) Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 Years	(37 k)
	Age
	Blood Type
	Residency
	Gender
	Race
	Center Volume
	Donor Age
	Cold Ischemic Time
	Hospitalized at Tx
	Level of HLA Mismatch
6.15	Unadjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Pancreas Transplant Alone (PTA) Transplants	(22 k)
6.16	Prevalence of People Living with a Functioning Transplant at End of Year Pancreas Transplant Alone (PTA) Recipients, 1997 to 2005	(37 k)
	Blood Type
	Residency
	Gender
	Race
	Age
	Hospitalized at Tx
	Previous Transplant Same Organ
	Previous Transplant Any Organ
6.17	Transplants by State and Transplant Center, 1997 to 2006 Pancreas Transplant Alone (PTA)	(54 k)
Section VII
7.1a	Waiting List Patient Characteristics at End of Year Pancreas After Kidney (PAK) Waiting List Active Waitlist Patients, 1997 to 2006	(37 k)
	Age
	Blood Type
	Residency
	Gender
	Race
	Previous Transplant Same Organ
	Time on Waiting List
7.1b	Waiting List Patient Characteristics at End of Year Pancreas After Kidney (PAK) Waiting List Active and Inactive Patient Comparison, 2002 to 2006	(33 k)
	Age
	Gender
	Race
	Time on Waiting List
7.2	Time to Transplant, 1997 to 2006 New Pancreas After Kidney (PAK) Waiting List Registrations	(49 k)
	Blood Type
	Age
	Gender
	All Patient Types
	Race
	Residency
7.3	Reported Deaths and Annual Death Rates Per 1,000 Patient-Years at Risk, 1997 to 2006 Pancreas After Kidney (PAK) Waiting List	(39 k)
	Age
	Blood Type
	Gender
	Race
7.4	Transplant Recipient Characteristics, 1997 to 2006 Pancreas After Kidney (PAK) Recipients	(39 k)
	Age
	Blood Type
	Residency
	Gender
	Race
	Cold Ischemic Time
	Hospitalized at Tx
	Previous Transplant Same Organ
	Payment Source
7.5	Incidence of Transplant, 1997 to 2006 Pancreas After Kidney (PAK) Transplants per 1 Million Population	(29 k)
7.6a	Immunosuppression Use for Induction, 1997 to 2006 Recipients with Pancreas After Kidney (PAK) Transplants	(29 k)
7.6b	Immunosuppression Use for Induction by Discharge Regimen, 2002 to 2006 Recipients with Pancreas After Kidney (PAK) Transplants	(31 k)
7.6c	Immunosuppression Use for Induction by Steroid Use at Discharge, 2002 to 2006 Recipients with Pancreas After Kidney (PAK) Transplants	(29 k)
7.6d	Immunosuppression Use for Maintenance by Regimen Prior to Discharge, 1997 to 2006 Recipients with Pancreas After Kidney (PAK) Transplants	(30 k)
7.6e	Immunosuppression Use for Maintenance Prior to Discharge, 1997 to 2006 Recipients with Pancreas After Kidney (PAK) Transplants	(31 k)
7.6f	Immunosuppression Use for Maintenance by Regimen One Year Following Transplantation, 1996 to 2005 Recipients with Pancreas After Kidney (PAK) Transplants	(31 k)
7.6g	Immunosuppression Use for Maintenance Between Discharge and One Year Following Transplantation, 1996 to 2005 Recipients with Pancreas After Kidney (PAK) Transplants	(31 k)
7.6h	Persistency of Discharge Regimen by Follow-up Period, 2001 to 2005 Recipients with Pancreas After Kidney (PAK) Transplants	(33 k)
7.6i	Immunosuppression Use for Antirejection Treatment from Transplant to One Year Following Transplantation, 1996 to 2005 Recipients with Pancreas After Kidney (PAK) Transplants	(30 k)
7.7	Patients and Annual Death Rates Per 1,000 Patient-Years at Risk, 1997 to 2005 Rates for Recipients during First Year after Pancreas After Kidney (PAK) Transplantation	(64 k)
	Blood Type
	Residency
	Gender
	Race
	Donor Age
	Age
	Cold Ischemic Time
	Hospitalized at Tx
	Level of HLA Mismatch
7.8	Adjusted Graft Survival, Pancreas After Kidney (PAK) Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 Years	(30 k)
	Age
	Gender
	Race
7.9	Adjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Pancreas After Kidney (PAK) Transplants	(22 k)
7.10	Unadjusted Graft Survival, Pancreas After Kidney (PAK) Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 Years	(37 k)
	Age
	Blood Type
	Residency
	Gender
	Race
	Center Volume
	Donor Age
	Cold Ischemic Time
	Hospitalized at Tx
	Level of HLA Mismatch
7.11	Unadjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Pancreas After Kidney (PAK) Transplants	(22 k)
7.12	Adjusted Patient Survival, Pancreas After Kidney (PAK) Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 Years	(30 k)
	Age
	Gender
	Race
7.13	Adjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Pancreas After Kidney (PAK) Transplants	(22 k)
7.14	Unadjusted Patient Survival, Pancreas After Kidney (PAK) Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 Years	(37 k)
	Age
	Blood Type
	Residency
	Gender
	Race
	Center Volume
	Donor Age
	Cold Ischemic Time
	Hospitalized at Tx
	Level of HLA Mismatch
7.15	Unadjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Pancreas After Kidney (PAK) Transplants	(22 k)
7.16	Prevalence of People Living with a Functioning Transplant at End of Year Pancreas After Kidney (PAK) Recipients, 1997 to 2005	(36 k)
	Blood Type
	Residency
	Gender
	Race
	Age
	Hospitalized at Tx
	Previous Transplant Same Organ
7.17	Transplants by State and Transplant Center, 1997 to 2006 Pancreas After Kidney (PAK)	(66 k)
Section VIII
8.1a	Waiting List Patient Characteristics at End of Year Kidney-Pancreas Waiting List Active Waitlist Patients, 1997 to 2006	(38 k)
	Age
	Blood Type
	Residency
	Gender
	Previous Transplant Any Organ
	Race
	Previous Transplant Same Organ
	Time on Waiting List
8.1b	Waiting List Patient Characteristics at End of Year Kidney-Pancreas Waiting List Active and Inactive Patient Comparison, 2002 to 2006	(33 k)
	Age
	Gender
	Race
	Time on Waiting List
8.2	Time to Transplant, 1997 to 2006 New Kidney-Pancreas Waiting List Registrations	(56 k)
	Blood Type
	Age
	Gender
	All Patient Types
	Previous Transplant Any Organ
	Race
	Residency
8.3	Reported Deaths and Annual Death Rates Per 1,000 Patient-Years at Risk, 1997 to 2006 Kidney-Pancreas Waiting List	(40 k)
	Age
	Blood Type
	Gender
	Race
8.4	Transplant Recipient Characteristics, 1997 to 2006 Kidney-Pancreas Recipients	(48 k)
	Age
	Blood Type
	Residency
	Gender
	Race
	Cold Ischemic Time
	Hospitalized at Tx
	Level of HLA Mismatch
	PRA
	Previous Transplant Same Organ
	Previous Transplant Any Organ
	Payment Source
8.5	Incidence of Transplant, 1997 to 2006 Kidney-Pancreas Transplants per 1 Million Population	(29 k)
8.6a	Immunosuppression Use for Induction, 1997 to 2006 Recipients with Kidney-Pancreas Transplants	(29 k)
8.6b	Immunosuppression Use for Induction by Discharge Regimen, 2002 to 2006 Recipients with Kidney-Pancreas Transplants	(31 k)
8.6c	Immunosuppression Use for Induction by Steroid Use at Discharge, 2002 to 2006 Recipients with Kidney-Pancreas Transplants	(29 k)
8.6d	Immunosuppression Use for Maintenance by Regimen Prior to Discharge, 1997 to 2006 Recipients with Kidney-Pancreas Transplants	(30 k)
8.6e	Immunosuppression Use for Maintenance Prior to Discharge, 1997 to 2006 Recipients with Kidney-Pancreas Transplants	(31 k)
8.6f	Immunosuppression Use for Maintenance by Regimen One Year Following Transplantation, 1996 to 2005 Recipients with Kidney-Pancreas Transplants	(31 k)
8.6g	Immunosuppression Use for Maintenance Between Discharge and One Year Following Transplantation, 1996 to 2005 Recipients with Kidney-Pancreas Transplants	(31 k)
8.6h	Persistency of Discharge Regimen by Follow-up Period, 2001 to 2005 Recipients with Kidney-Pancreas Transplants	(33 k)
8.6i	Immunosuppression Use for Antirejection Treatment from Transplant to One Year Following Transplantation, 1996 to 2005 Recipients with Kidney-Pancreas Transplants	(30 k)
8.7	Patients and Annual Death Rates Per 1,000 Patient-Years at Risk, 1997 to 2005 Rates for Recipients during First Year after Kidney-Pancreas Transplantation	(77 k)
	Blood Type
	Residency
	Gender
	PRA
	Race
	Donor Age
	Age
	Cold Ischemic Time
	Hospitalized at Tx
	Level of HLA Mismatch
	Previous Kidney Transplant
	Previous Pancreas Transplant
	Previous Transplant Any Organ
8.8	Adjusted Graft Survival, Kidney-Pancreas Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 Years	(34 k)
	Kidney Graft - by Age
	Pancreas Graft - by Age
	Kidney Graft - by Gender
	Pancreas Graft - by Gender
	Kidney Graft - by Race
	Pancreas Graft - by Race
8.9a	Adjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Kidney-Pancreas Transplants - Kidney Graft	(22 k)
8.9b	Adjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Kidney-Pancreas Transplants - Pancreas Graft	(22 k)
8.10	Unadjusted Graft Survival, Kidney-Pancreas Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 Years	(59 k)
	Kidney Graft - by Age
	Pancreas Graft - by Age
	Kidney Graft - by Blood Type
	Pancreas Graft - by Blood Type
	Kidney Graft - by Residency
	Pancreas Graft - by Residency
	Kidney Graft - by Gender
	Pancreas Graft - by Gender
	Kidney Graft - by PRA
	Pancreas Graft - by PRA
	Kidney Graft - by Race
	Pancreas Graft - by Race
	Kidney Graft - by Center Volume
	Pancreas Graft - by Center Volume
	Kidney Graft - by Donor Age
	Pancreas Graft - by Donor Age
	Previous Transplant Same Organ Kidney Graft
	Previous Transplant Same Organ Pancreas Graft
	Kidney Graft - by Cold Ischemic Time
	Kidney Graft - by Hospitalized at Tx
	Pancreas Graft - by Hospitalized at Tx
	Kidney Graft - by Level of HLA Mismatch
	Pancreas Graft - by Level of HLA Mismatch
	Kidney Graft - by Previous Kidney Transplant
	Pancreas Graft - by Previous Kidney Transplant
	Kidney Graft - by Previous Pancreas Transplant
	Pancreas Graft - by Previous Pancreas Transplant
8.11a	Unadjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Kidney-Pancreas Transplants - Kidney Graft	(22 k)
8.11b	Unadjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Kidney-Pancreas Transplants - Pancreas Graft	(22 k)
8.12	Adjusted Patient Survival, Kidney-Pancreas Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 Years	(30 k)
	Age
	Gender
	Race
8.13	Adjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years	(22 k)
8.14	Unadjusted Patient Survival, Kidney-Pancreas Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 Years	(44 k)
	Age
	Blood Type
	Residency
	Gender
	PRA
	Race
	Center Volume
	Donor Age
	Cold Ischemic Time
	Hospitalized at Tx
	Level of HLA Mismatch
8.15	Unadjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years	(22 k)
8.16	Prevalence of People Living with a Functioning Transplant at End of Year Kidney-Pancreas Recipients, 1997 to 2005	(44 k)
	Blood Type
	Residency
	Gender
	Race
	Age
	Hospitalized at Tx
	Level of HLA Mismatch
	PRA
	Previous Transplant Same Organ
	Previous Transplant Any Organ
8.17	Transplants by State and Transplant Center, 1997 to 2006 Kidney-Pancreas	(70 k)
Section IX
9.1a	Waiting List Patient Characteristics at End of Year Liver Waiting List Active Waitlist Patients, 1997 to 2006	(47 k)
	Age
	Blood Type
	Residency
	Diagnosis
	Gender
	Previous Transplant Any Organ
	Race
	Patient Status
	Previous Transplant Same Organ
	Time on Waiting List
9.1b	Waiting List Patient Characteristics at End of Year Liver Waiting List Active and Inactive Patient Comparison, 2002 to 2006	(37 k)
	Age
	Diagnosis
	Gender
	Race
	Time on Waiting List
9.2a	Events 7 & 15 Days After Listing 2005 and 2006 Liver Registrations with Initial Status 1	(22 k)
9.2b	Events 30 Days After Snapshot of Prevalent Waiting List Adult Patients on Liver Waiting List on Jan. 1, 2006	(36 k)
	30 Days After Snapshot
	60 Days After Snapshot
	90 Days After Snapshot
9.2c	Events 30 Days After Snapshot of Prevalent Waiting List Pediatric Patients on Liver Waiting List on Jan. 1, 2006	(35 k)
	30 Days After Snapshot
	60 Days After Snapshot
	90 Days After Snapshot
9.3	Reported Deaths and Annual Death Rates Per 1,000 Patient-Years at Risk, 1997 to 2006 Liver Waiting List	(58 k)
	Age
	Blood Type
	Diagnosis
	Gender
	Race
	Patient Status
9.4a	Transplant Recipient Characteristics, 1997 to 2006 Recipients of Deceased Donor Livers	(49 k)
	Age
	Blood Type
	Residency
	Gender
	Patient Status
	Race
	Diagnosis
	Cold Ischemic Time
	On Life Support at Tx
	Hospitalized at Tx
	Previous Transplant Same Organ
	Previous Transplant Any Organ
	Payment Source
	Procedure Type
9.4b	Transplant Recipient Characteristics, 1997 to 2006 Recipients of Living Donor Livers	(48 k)
	Age
	Blood Type
	Residency
	Gender
	Patient Status
	Race
	Donor Relation
	Diagnosis
	On Life Support at Tx
	Hospitalized at Tx
	Previous Transplant Same Organ
	Previous Transplant Any Organ
	Payment Source
9.5	Incidence of Transplant, 1997 to 2006 Liver Transplants per 1 Million Population	(29 k)
9.6a	Immunosuppression Use for Induction, 1997 to 2006 Recipients with Liver Transplants	(29 k)
9.6b	Immunosuppression Use for Induction by Discharge Regimen, 2002 to 2006 Recipients with Liver Transplants	(31 k)
9.6c	Immunosuppression Use for Induction by Steroid Use at Discharge, 2002 to 2006 Recipients with Liver Transplants	(29 k)
9.6d	Immunosuppression Use for Maintenance by Regimen Prior to Discharge, 1997 to 2006 Recipients with Liver Transplants	(30 k)
9.6e	Immunosuppression Use for Maintenance Prior to Discharge, 1997 to 2006 Recipients with Liver Transplants	(31 k)
9.6f	Immunosuppression Use for Maintenance by Regimen One Year Following Transplantation, 1996 to 2005 Recipients with Liver Transplants	(31 k)
9.6g	Immunosuppression Use for Maintenance Between Discharge and One Year Following Transplantation, 1996 to 2005 Recipients with Liver Transplants	(31 k)
9.6h	Persistency of Discharge Regimen by Follow-up Period, 2001 to 2005 Recipients with Liver Transplants	(34 k)
9.6i	Immunosuppression Use for Antirejection Treatment from Transplant to One Year Following Transplantation, 1996 to 2005 Recipients with Liver Transplants	(30 k)
9.7a	Patients and Annual Death Rates Per 1,000 Patient-Years at Risk, 1997 to 2005 Rates for Recipients during First Year after Deceased Donor Liver Transplantation	(82 k)
	Blood Type
	Residency
	Gender
	Patient Status
	Race
	Donor Age
	Age
	Cold Ischemic Time
	On Life Support at Tx
	Hospitalized at Tx
	Previous Transplant Any Organ
	Diagnosis
9.7b	Patients and Annual Death Rates Per 1,000 Patient-Years at Risk, 1997 to 2005 Rates for Recipients during First Year after Living Donor Liver Transplantation	(74 k)
	Blood Type
	Residency
	Gender
	Patient Status
	Race
	Donor Age
	Age
	On Life Support at Tx
	Hospitalized at Tx
	Previous Transplant Any Organ
	Diagnosis
9.8a	Adjusted Graft Survival, Deceased Donor Liver Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 Years	(36 k)
	Age
	Gender
	Race
	Diagnosis
9.8b	Adjusted Graft Survival, Living Donor Liver Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 Years	(36 k)
	Age
	Gender
	Race
	Diagnosis
9.9a	Adjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Deceased Donor Liver Transplants	(22 k)
9.9b	Adjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Living Donor Liver Transplants	(22 k)
9.10a	Unadjusted Graft Survival, Deceased Donor Liver Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 Years	(47 k)
	Age
	Blood Type
	Residency
	Gender
	Patient Status
	Race
	Center Volume
	Donor Age
	Previous Transplant Same Organ
	Diagnosis
	Cold Ischemic Time
	On Life Support at Tx
	Hospitalized at Tx
9.10b	Unadjusted Graft Survival, Living Donor Liver Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 Years	(46 k)
	Age
	Blood Type
	Residency
	Gender
	Patient Status
	Race
	Center Volume
	Donor Relation
	Donor Age
	Previous Transplant Same Organ
	Diagnosis
	On Life Support at Tx
	Hospitalized at Tx
9.11a	Unadjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Deceased Donor Liver Transplants	(22 k)
9.11b	Unadjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Living Donor Liver Transplants	(22 k)
9.12a	Adjusted Patient Survival, Deceased Donor Liver Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 Years	(36 k)
	Age
	Gender
	Race
	Diagnosis
9.12b	Adjusted Patient Survival, Living Donor Liver Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 Years	(36 k)
	Age
	Gender
	Race
	Diagnosis
9.13a	Adjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Deceased Donor Liver Transplants	(22 k)
9.13b	Adjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Living Donor Liver Transplants	(22 k)
9.14a	Unadjusted Patient Survival, Deceased Donor Liver Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 Years	(47 k)
	Age
	Blood Type
	Residency
	Gender
	Patient Status
	Race
	Center Volume
	Donor Age
	Diagnosis
	Cold Ischemic Time
	On Life Support at Tx
	Hospitalized at Tx
9.14b	Unadjusted Patient Survival, Living Donor Liver Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 Years	(46 k)
	Age
	Blood Type
	Residency
	Gender
	Patient Status
	Race
	Center Volume
	Donor Relation
	Donor Age
	Diagnosis
	On Life Support at Tx
	Hospitalized at Tx
9.15a	Unadjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Deceased Donor Liver Transplants	(22 k)
9.15b	Unadjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Living Donor Liver Transplants	(22 k)
9.16	Prevalence of People Living with a Functioning Transplant at End of Year Liver Recipients, 1997 to 2005	(47 k)
	Blood Type
	Residency
	Gender
	Patient Status
	Race
	Donor Type
	Age
	Diagnosis
	On Life Support at Tx
	Hospitalized at Tx
	Previous Transplant Same Organ
	Previous Transplant Any Organ
9.17	Transplants by State and Transplant Center, 1997 to 2006 Liver	(67 k)
Section X
10.1a	Waiting List Patient Characteristics at End of Year Intestine Waiting List Active Waitlist Patients, 1997 to 2006	(41 k)
	Age
	Blood Type
	Residency
	Diagnosis
	Gender
	Previous Transplant Any Organ
	Race
	Previous Transplant Same Organ
	Time on Waiting List
10.1b	Waiting List Patient Characteristics at End of Year Intestine Waiting List Active and Inactive Patient Comparison, 2002 to 2006	(36 k)
	Age
	Diagnosis
	Gender
	Race
	Time on Waiting List
10.2	Time to Transplant, 1997 to 2006 New Intestine Waiting List Registrations	(55 k)
	Blood Type
	Age
	Gender
	All Patient Types
	Previous Transplant Any Organ
	Race
	Residency
10.3	Reported Deaths and Annual Death Rates Per 1,000 Patient-Years at Risk, 1997 to 2006 Intestine Waiting List	(45 k)
	Age
	Blood Type
	Diagnosis
	Gender
	Race
10.4	Transplant Recipient Characteristics, 1997 to 2006 Intestine Recipients	(42 k)
	Age
	Blood Type
	Residency
	Gender
	Race
	Diagnosis
	Cold Ischemic Time
	On Life Support at Tx
	Hospitalized at Tx
	Previous Transplant Same Organ
	Previous Transplant Any Organ
	Payment Source
10.5	Incidence of Transplant, 1997 to 2006 Intestine Transplants per 1 Million Population	(29 k)
10.6a	Immunosuppression Use for Induction, 1997 to 2006 Recipients with Intestine Transplants	(29 k)
10.6b	Immunosuppression Use for Induction by Discharge Regimen, 2002 to 2006 Recipients with Intestine Transplants	(31 k)
10.6c	Immunosuppression Use for Induction by Steroid Use at Discharge, 2002 to 2006 Recipients with Intestine Transplants	(28 k)
10.6d	Immunosuppression Use for Maintenance by Regimen Prior to Discharge, 1997 to 2006 Recipients with Intestine Transplants	(29 k)
10.6e	Immunosuppression Use for Maintenance Prior to Discharge, 1997 to 2006 Recipients with Intestine Transplants	(30 k)
10.6f	Immunosuppression Use for Maintenance by Regimen One Year Following Transplantation, 1996 to 2005 Recipients with Intestine Transplants	(31 k)
10.6g	Immunosuppression Use for Maintenance Between Discharge and One Year Following Transplantation, 1996 to 2005 Recipients with Intestine Transplants	(31 k)
10.6h	Persistency of Discharge Regimen by Follow-up Period, 2001 to 2005 Recipients with Intestine Transplants	(29 k)
10.6i	Immunosuppression Use for Antirejection Treatment from Transplant to One Year Following Transplantation, 1996 to 2005 Recipients with Intestine Transplants	(30 k)
10.7	Patients and Annual Death Rates Per 1,000 Patient-Years at Risk, 1997 to 2005 Rates for Recipients during First Year after Intestine Transplantation	(68 k)
	Blood Type
	Residency
	Gender
	Race
	Donor Age
	Age
	Cold Ischemic Time
	On Life Support at Tx
	Hospitalized at Tx
	Previous Transplant Any Organ
	Diagnosis
10.8	Adjusted Graft Survival, Intestine Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 Years	(36 k)
	Age
	Gender
	Race
	Diagnosis
10.9	Adjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Intestine Transplants	(22 k)
10.10	Unadjusted Graft Survival, Intestine Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 Years	(42 k)
	Age
	Blood Type
	Residency
	Gender
	Race
	Center Volume
	Donor Age
	Previous Transplant Same Organ
	Diagnosis
	Cold Ischemic Time
	On Life Support at Tx
	Hospitalized at Tx
10.11	Unadjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Intestine Transplants	(22 k)
10.12	Adjusted Patient Survival, Intestine Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 Years	(36 k)
	Age
	Gender
	Race
	Diagnosis
10.13	Adjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Intestine Transplants	(22 k)
10.14	Unadjusted Patient Survival, Intestine Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 Years	(42 k)
	Age
	Blood Type
	Residency
	Gender
	Race
	Center Volume
	Donor Age
	Diagnosis
	Cold Ischemic Time
	On Life Support at Tx
	Hospitalized at Tx
10.15	Unadjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Intestine Transplants	(22 k)
10.16	Prevalence of People Living with a Functioning Transplant at End of Year Intestine Recipients, 1997 to 2005	(40 k)
	Blood Type
	Residency
	Gender
	Race
	Age
	Diagnosis
	On Life Support at Tx
	Hospitalized at Tx
	Previous Transplant Same Organ
	Previous Transplant Any Organ
10.17	Transplants by State and Transplant Center, 1997 to 2006 Intestine	(40 k)
Section XI
11.1a	Waiting List Patient Characteristics at End of Year Heart Waiting List Active Waitlist Patients, 1997 to 2006	(42 k)
	Age
	Blood Type
	Residency
	Diagnosis
	Gender
	Previous Transplant Any Organ
	Race
	Patient Status
	Previous Transplant Same Organ
	Time on Waiting List
11.1b	Waiting List Patient Characteristics at End of Year Heart Waiting List Active and Inactive Patient Comparison, 2002 to 2006	(37 k)
	Age
	Diagnosis
	Gender
	Race
	Time on Waiting List
11.2a	Events 7 & 30 Days After Listing 2005 and 2006 Heart Registrations with Initial Status 1A	(20 k)
11.2b	Events 30 Days After Snapshot of Prevalent Waiting List Patients on Heart Waiting List on Jan. 1, 2006	(33 k)
	30 Days After Snapshot
	60 Days After Snapshot
	90 Days After Snapshot
11.3	Reported Deaths and Annual Death Rates Per 1,000 Patient-Years at Risk, 1997 to 2006 Heart Waiting List	(50 k)
	Age
	Blood Type
	Diagnosis
	Gender
	Race
	Patient Status
11.4	Transplant Recipient Characteristics, 1997 to 2006 Heart Recipients	(46 k)
	Age
	Blood Type
	Residency
	Gender
	Patient Status
	Race
	Diagnosis
	Cold Ischemic Time
	On Life Support at Tx
	Hospitalized at Tx
	Previous Transplant Same Organ
	Previous Transplant Any Organ
	Payment Source
	Procedure Type
11.5	Incidence of Transplant, 1997 to 2006 Heart Transplants per 1 Million Population	(29 k)
11.6a	Immunosuppression Use for Induction, 1997 to 2006 Recipients with Heart Transplants	(29 k)
11.6b	Immunosuppression Use for Induction by Discharge Regimen, 2002 to 2006 Recipients with Heart Transplants	(31 k)
11.6c	Immunosuppression Use for Induction by Steroid Use at Discharge, 2002 to 2006 Recipients with Heart Transplants	(29 k)
11.6d	Immunosuppression Use for Maintenance by Regimen Prior to Discharge, 1997 to 2006 Recipients with Heart Transplants	(30 k)
11.6e	Immunosuppression Use for Maintenance Prior to Discharge, 1997 to 2006 Recipients with Heart Transplants	(31 k)
11.6f	Immunosuppression Use for Maintenance by Regimen One Year Following Transplantation, 1996 to 2005 Recipients with Heart Transplants	(31 k)
11.6g	Immunosuppression Use for Maintenance Between Discharge and One Year Following Transplantation, 1996 to 2005 Recipients with Heart Transplants	(31 k)
11.6h	Persistency of Discharge Regimen by Follow-up Period, 2001 to 2005 Recipients with Heart Transplants	(33 k)
11.6i	Immunosuppression Use for Antirejection Treatment from Transplant to One Year Following Transplantation, 1996 to 2005 Recipients with Heart Transplants	(30 k)
11.7	Patients and Annual Death Rates Per 1,000 Patient-Years at Risk, 1997 to 2005 Rates for Recipients during First Year after Heart Transplantation	(75 k)
	Blood Type
	Residency
	Gender
	Patient Status
	Race
	Donor Age
	Procedure Type
	Age
	Cold Ischemic Time
	On Life Support at Tx
	Hospitalized at Tx
	Previous Transplant Any Organ
	Diagnosis
11.8	Adjusted Graft Survival, Heart Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 Years	(36 k)
	Age
	Gender
	Race
	Diagnosis
11.9	Adjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Heart Transplants	(22 k)
11.10	Unadjusted Graft Survival, Heart Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 Years	(46 k)
	Age
	Blood Type
	Residency
	Gender
	Patient Status
	Race
	Center Volume
	Donor Age
	Previous Transplant Same Organ
	Procedure Type
	Diagnosis
	Cold Ischemic Time
	On Life Support at Tx
	Hospitalized at Tx
11.11	Unadjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Heart Transplants	(22 k)
11.12	Adjusted Patient Survival, Heart Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 Years	(36 k)
	Age
	Gender
	Race
	Diagnosis
11.13	Adjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Heart Transplants	(22 k)
11.14	Unadjusted Patient Survival, Heart Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 Years	(46 k)
	Age
	Blood Type
	Residency
	Gender
	Patient Status
	Race
	Center Volume
	Donor Age
	Procedure Type
	Diagnosis
	Cold Ischemic Time
	On Life Support at Tx
	Hospitalized at Tx
11.15	Unadjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Heart Transplants	(22 k)
11.16	Prevalence of People Living with a Functioning Transplant at End of Year Heart Recipients, 1997 to 2005	(43 k)
	Blood Type
	Residency
	Gender
	Patient Status
	Race
	Age
	Diagnosis
	On Life Support at Tx
	Hospitalized at Tx
	Previous Transplant Same Organ
	Previous Transplant Any Organ
	Procedure Type
11.17	Transplants by State and Transplant Center, 1997 to 2006 Heart	(70 k)
Section XII
12.1a	Waiting List Patient Characteristics at End of Year Lung Waiting List Active Waitlist Patients, 1997 to 2006	(42 k)
	Age
	Blood Type
	Residency
	Diagnosis
	Gender
	Previous Transplant Any Organ
	Race
	Previous Transplant Same Organ
	Time on Waiting List
12.1b	Waiting List Patient Characteristics at End of Year Lung Waiting List Active and Inactive Patient Comparison, 2002 to 2006	(37 k)
	Age
	Diagnosis
	Gender
	Race
	Time on Waiting List
12.2	Time to Transplant, 1997 to 2006 New Lung Waiting List Registrations	(54 k)
	Blood Type
	Age
	Gender
	All Patient Types
	Previous Transplant Any Organ
	Race
	Residency
12.3	Reported Deaths and Annual Death Rates Per 1,000 Patient-Years at Risk, 1997 to 2006 Lung Waiting List	(49 k)
	Age
	Blood Type
	Diagnosis
	Gender
	Race
12.4a	Transplant Recipient Characteristics, 1997 to 2006 Recipients of Deceased Donor Lungs	(46 k)
	Age
	Blood Type
	Residency
	Gender
	Race
	Diagnosis
	Cold Ischemic Time
	On Life Support at Tx
	Hospitalized at Tx
	Previous Transplant Same Organ
	Previous Transplant Any Organ
	Payment Source
	Procedure Type
12.4b	Transplant Recipient Characteristics, 1997 to 2006 Recipients of Living Donor Lungs	(45 k)
	Age
	Blood Type
	Residency
	Gender
	Race
	Donor Relation
	Diagnosis
	On Life Support at Tx
	Hospitalized at Tx
	Previous Transplant Same Organ
	Previous Transplant Any Organ
	Payment Source
	Procedure Type
12.5	Incidence of Transplant, 1997 to 2006 Lung Transplants per 1 Million Population	(29 k)
12.6a	Immunosuppression Use for Induction, 1997 to 2006 Recipients with Lung Transplants	(29 k)
12.6b	Immunosuppression Use for Induction by Discharge Regimen, 2002 to 2006 Recipients with Lung Transplants	(31 k)
12.6c	Immunosuppression Use for Induction by Steroid Use at Discharge, 2002 to 2006 Recipients with Lung Transplants	(29 k)
12.6d	Immunosuppression Use for Maintenance by Regimen Prior to Discharge, 1997 to 2006 Recipients with Lung Transplants	(30 k)
12.6e	Immunosuppression Use for Maintenance Prior to Discharge, 1997 to 2006 Recipients with Lung Transplants	(31 k)
12.6f	Immunosuppression Use for Maintenance by Regimen One Year Following Transplantation, 1996 to 2005 Recipients with Lung Transplants	(31 k)
12.6g	Immunosuppression Use for Maintenance Between Discharge and One Year Following Transplantation, 1996 to 2005 Recipients with Lung Transplants	(31 k)
12.6h	Persistency of Discharge Regimen by Follow-up Period, 2001 to 2005 Recipients with Lung Transplants	(33 k)
12.6i	Immunosuppression Use for Antirejection Treatment from Transplant to One Year Following Transplantation, 1996 to 2005 Recipients with Lung Transplants	(30 k)
12.7a	Patients and Annual Death Rates Per 1,000 Patient-Years at Risk, 1997 to 2005 Rates for Recipients during First Year after Deceased Donor Lung Transplantation	(75 k)
	Blood Type
	Residency
	Gender
	Race
	Donor Age
	Procedure Type
	Age
	Cold Ischemic Time
	On Life Support at Tx
	Hospitalized at Tx
	Previous Transplant Any Organ
	Diagnosis
12.7b	Patients and Annual Death Rates Per 1,000 Patient-Years at Risk, 1997 to 2005 Rates for Recipients during First Year after Living Donor Lung Transplantation	(63 k)
	Blood Type
	Residency
	Gender
	Race
	Donor Age
	Procedure Type
	Age
	On Life Support at Tx
	Hospitalized at Tx
	Previous Transplant Any Organ
	Diagnosis
12.8	Adjusted Graft Survival, Deceased Donor Lung Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 Years	(36 k)
	Age
	Gender
	Race
	Diagnosis
12.9a	Adjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Deceased Donor Lung Transplants	(22 k)
12.10a	Unadjusted Graft Survival, Deceased Donor Lung Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 Years	(43 k)
	Age
	Blood Type
	Residency
	Gender
	Race
	Center Volume
	Donor Age
	Previous Transplant Same Organ
	Procedure Type
	Diagnosis
	Cold Ischemic Time
	On Life Support at Tx
	Hospitalized at Tx
12.10b	Unadjusted Graft Survival, Living Donor Lung Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 Years	(41 k)
	Age
	Blood Type
	Residency
	Gender
	Race
	Center Volume
	Donor Relation
	Donor Age
	Previous Transplant Same Organ
	Diagnosis
	On Life Support at Tx
	Hospitalized at Tx
12.11a	Unadjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Deceased Donor Lung Transplants	(22 k)
12.11b	Unadjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Living Donor Lung Transplants	(22 k)
12.12	Adjusted Patient Survival, Deceased Donor Lung Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 Years	(36 k)
	Age
	Gender
	Race
	Diagnosis
12.13a	Adjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Deceased Donor Lung Transplants	(22 k)
12.14a	Unadjusted Patient Survival, Deceased Donor Lung Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 Years	(43 k)
	Age
	Blood Type
	Residency
	Gender
	Race
	Center Volume
	Donor Age
	Procedure Type
	Diagnosis
	Cold Ischemic Time
	On Life Support at Tx
	Hospitalized at Tx
12.14b	Unadjusted Patient Survival, Living Donor Lung Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 Years	(40 k)
	Age
	Blood Type
	Residency
	Gender
	Race
	Center Volume
	Donor Relation
	Donor Age
	Diagnosis
	On Life Support at Tx
	Hospitalized at Tx
12.15a	Unadjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Deceased Donor Lung Transplants	(22 k)
12.15b	Unadjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Living Donor Lung Transplants	(22 k)
12.16	Prevalence of People Living with a Functioning Transplant at End of Year Lung Recipients, 1997 to 2005	(43 k)
	Blood Type
	Residency
	Gender
	Race
	Age
	Diagnosis
	On Life Support at Tx
	Hospitalized at Tx
	Previous Transplant Same Organ
	Previous Transplant Any Organ
	Procedure Type
12.17	Transplants by State and Transplant Center, 1997 to 2006 Lung	(52 k)
Section XIII
13.1a	Waiting List Patient Characteristics at End of Year Heart-Lung Waiting List Active Waitlist Patients, 1997 to 2006	(41 k)
	Age
	Blood Type
	Residency
	Diagnosis
	Gender
	Previous Transplant Any Organ
	Race
	Previous Transplant Same Organ
	Time on Waiting List
13.1b	Waiting List Patient Characteristics at End of Year Heart-Lung Waiting List Active and Inactive Patient Comparison, 2002 to 2006	(36 k)
	Age
	Diagnosis
	Gender
	Race
	Time on Waiting List
13.2	Time to Transplant, 1997 to 2006 New Heart-Lung Waiting List Registrations	(54 k)
	Blood Type
	Age
	Gender
	All Patient Types
	Previous Transplant Any Organ
	Race
	Residency
13.3	Reported Deaths and Annual Death Rates Per 1,000 Patient-Years at Risk, 1997 to 2006 Heart-Lung Waiting List	(46 k)
	Age
	Blood Type
	Diagnosis
	Gender
	Race
13.4	Transplant Recipient Characteristics, 1997 to 2006 Heart-Lung Recipients	(41 k)
	Age
	Blood Type
	Residency
	Gender
	Race
	Diagnosis
	On Life Support at Tx
	Hospitalized at Tx
	Previous Transplant Same Organ
	Previous Transplant Any Organ
	Payment Source
13.5	Incidence of Transplant, 1997 to 2006 Heart-Lung Transplants per 1 Million Population	(28 k)
13.6a	Immunosuppression Use for Induction, 1997 to 2006 Recipients with Heart-Lung Transplants	(29 k)
13.6b	Immunosuppression Use for Induction by Discharge Regimen, 2002 to 2006 Recipients with Heart-Lung Transplants	(31 k)
13.6c	Immunosuppression Use for Induction by Steroid Use at Discharge, 2002 to 2006 Recipients with Heart-Lung Transplants	(28 k)
13.6d	Immunosuppression Use for Maintenance by Regimen Prior to Discharge, 1997 to 2006 Recipients with Heart-Lung Transplants	(29 k)
13.6e	Immunosuppression Use for Maintenance Prior to Discharge, 1997 to 2006 Recipients with Heart-Lung Transplants	(31 k)
13.6f	Immunosuppression Use for Maintenance by Regimen One Year Following Transplantation, 1996 to 2005 Recipients with Heart-Lung Transplants	(31 k)
13.6g	Immunosuppression Use for Maintenance Between Discharge and One Year Following Transplantation, 1996 to 2005 Recipients with Heart-Lung Transplants	(31 k)
13.6h	Persistency of Discharge Regimen by Follow-up Period, 2001 to 2005 Recipients with Heart-Lung Transplants	(30 k)
13.6i	Immunosuppression Use for Antirejection Treatment from Transplant to One Year Following Transplantation, 1996 to 2005 Recipients with Heart-Lung Transplants	(30 k)
13.7	Patients and Annual Death Rates Per 1,000 Patient-Years at Risk, 1997 to 2005 Rates for Recipients during First Year after Heart-Lung Transplantation	(65 k)
	Blood Type
	Residency
	Gender
	Race
	Donor Age
	Age
	Cold Ischemic Time
	On Life Support at Tx
	Hospitalized at Tx
	Previous Transplant Any Organ
	Diagnosis
13.8	Adjusted Graft Survival, Heart-Lung Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 Years	(36 k)
	Age
	Gender
	Race
	Diagnosis
13.9	Adjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Heart-Lung Transplants	(22 k)
13.10	Unadjusted Graft Survival, Heart-Lung Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 Years	(42 k)
	Age
	Blood Type
	Residency
	Gender
	Race
	Center Volume
	Donor Age
	Previous Transplant Same Organ
	Diagnosis
	Cold Ischemic Time
	On Life Support at Tx
	Hospitalized at Tx
13.11	Unadjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Heart-Lung Transplants	(22 k)
13.12	Adjusted Patient Survival, Heart-Lung Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 Years	(36 k)
	Age
	Gender
	Race
	Diagnosis
13.13	Adjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Heart-Lung Transplants	(22 k)
13.14	Unadjusted Patient Survival, Heart-Lung Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 Years	(41 k)
	Age
	Blood Type
	Residency
	Gender
	Race
	Center Volume
	Donor Age
	Diagnosis
	Cold Ischemic Time
	On Life Support at Tx
	Hospitalized at Tx
13.15	Unadjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Heart-Lung Transplants	(22 k)
13.16	Prevalence of People Living with a Functioning Transplant at End of Year Heart-Lung Recipients, 1997 to 2005	(40 k)
	Blood Type
	Residency
	Gender
	Race
	Age
	Diagnosis
	On Life Support at Tx
	Hospitalized at Tx
	Previous Transplant Same Organ
	Previous Transplant Any Organ
13.17	Transplants by State and Transplant Center, 1997 to 2006 Heart-Lung	(47 k)
Section XIV
14.1	History of Cancer among Deceased Donors, 1997 to 2006	(30 k)
14.2	Recipient Recurrence of Pretransplant Malignancies, 1997 to 2006	(38 k)
14.3	Recipient De Novo Post Transplant Solid Malignancies, 1997 to 2006 by Transplant Type	(31 k)
14.4	Recipient De Novo Post Transplant Lymphoproliferative Disorders (PTLD), 1997 to 2006 by Transplant Type	(30 k)
14.5	History of Cancer among Deceased Kidney Donors 1997 to 2006	(30 k)
14.6	De Novo Post Transplant Solid Malignancy, 1997 to 2006 Kidney Recipients	(32 k)
14.7	History of Cancer among Deceased Liver Donors 1997 to 2006	(30 k)
14.8	De Novo Post Transplant Solid Malignancy, 1997 to 2006 Liver Recipients	(32 k)
14.9	History of Cancer among Deceased Heart Donors 1997 to 2006	(30 k)
14.10	De Novo Post Transplant Solid Malignancy, 1997 to 2006 Heart Recipients	(32 k)
Section XV
15.1	Waiting Time Before Transplant - Excluding Inactive Time, Censored at WL Removal New Waiting List Registrations, 1997 to 2006	(36 k)
15.2	Time to Transplant, 1997 to 2006 New Liver Waiting List Registrations	(71 k)
	Blood Type
	Age
	Gender
	All Patient Types
	Patient Status
	Previous Transplant Any Organ
	Race
	Residency
15.3	Time to Transplant, 1997 to 2006 New Heart Waiting List Registrations	(59 k)
	Blood Type
	Age
	Gender
	All Patient Types
	Patient Status
	Previous Transplant Any Organ
	Race
	Residency
15.4a	Steroid Avoidance Rate at Discharge, 1997 to 2006 Recipients of Deceased Donor Kidneys	(38 k)
	Steroid Avoidance Rate at Discharge, 1997 to 2006 Recipients of Deceased Donor Kidneys
	Steroid Withdrawal Rate at One Year Following Transplantation, 1999 to 2005 Recipients of Deceased Donor Kidneys
	Steroid Withdrawal Rate at Two Years Following Transplantation, 1998 to 2004 Recipients of Deceased Donor Kidneys
15.4b	Steroid Avoidance Rate at Discharge, 1997 to 2006 Recipients of Living Donor Kidneys	(38 k)
	Steroid Avoidance Rate at Discharge, 1997 to 2006 Recipients of Living Donor Kidneys
	Steroid Withdrawal Rate at One Year Following Transplantation, 1999 to 2005 Recipients of Living Donor Kidneys
	Steroid Withdrawal Rate at Two Years Following Transplantation, 1998 to 2004 Recipients of Living Donor Kidneys
15.5a	Steroid Avoidance Rate at Discharge, 1997 to 2006 Recipients of Deceased Donor Livers	(38 k)
	Steroid Avoidance Rate at Discharge, 1997 to 2006 Recipients of Deceased Donor Livers
	Steroid Withdrawal Rate at One Year Following Transplantation, 1999 to 2005 Recipients of Deceased Donor Livers
	Steroid Withdrawal Rate at Two Years Following Transplantation, 1998 to 2004 Recipients of Deceased Donor Livers
15.5b	Steroid Avoidance Rate at Discharge, 1997 to 2006 Recipients of Living Donor Livers	(37 k)
	Steroid Avoidance Rate at Discharge, 1997 to 2006 Recipients of Living Donor Livers
	Steroid Withdrawal Rate at One Year Following Transplantation, 1999 to 2005 Recipients of Living Donor Livers
	Steroid Withdrawal Rate at Two Years Following Transplantation, 1998 to 2004 Recipients of Living Donor Livers
15.6	Steroid Avoidance Rate at Discharge, 1997 to 2006 Recipients of Heart Transplants	(37 k)
	Steroid Avoidance Rate at Discharge, 1997 to 2006 Recipients of Heart Transplants
	Steroid Withdrawal Rate at One Year Following Transplantation, 1999 to 2005 Recipients of Heart Transplants
	Steroid Withdrawal Rate at Two Years Following Transplantation, 1998 to 2004 Recipients of Heart Transplants
15.7	Immunosuppression Use for Maintenance by Regimen Two Years Following Transplantation, 1998 to 2004 Recipients with Kidney Transplants	(31 k)
15.8	Immunosuppression Use for Maintenance by Regimen Two Years Following Transplantation, 1998 to 2004 Recipients with Pancreas Transplant Alone (PTA) Transplants	(31 k)
15.9	Immunosuppression Use for Maintenance by Regimen Two Years Following Transplantation, 1998 to 2004 Recipients with Pancreas After Kidney (PAK) Transplants	(31 k)
15.10	Immunosuppression Use for Maintenance by Regimen Two Years Following Transplantation, 1998 to 2004 Recipients with Kidney-Pancreas Transplants	(31 k)
15.11	Immunosuppression Use for Maintenance by Regimen Two Years Following Transplantation, 1998 to 2004 Recipients with Liver Transplants	(31 k)
15.12	Immunosuppression Use for Maintenance by Regimen Two Years Following Transplantation, 1998 to 2004 Recipients with Intestine Transplants	(31 k)
15.13	Immunosuppression Use for Maintenance by Regimen Two Years Following Transplantation, 1998 to 2004 Recipients with Heart Transplants	(31 k)
15.14	Immunosuppression Use for Maintenance by Regimen Two Years Following Transplantation, 1998 to 2004 Recipients with Lung Transplants	(31 k)
15.15	Immunosuppression Use for Maintenance by Regimen Two Years Following Transplantation, 1998 to 2004 Recipients with Heart-Lung Transplants	(31 k)